More on DNTH

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-2.1% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Dianthus Therapeutics (NQ:DNTH)
Delayed: 106.71 -0.33 (0.31%)
Prev. Close $107.04  
Open$105.88 
52 Wk High$ 
52 Wk Low$ 
Day High$106.81 
Day Low$101.60 
P/E N/A  
EPS$ 
Volume17,365 

Friends, Peers and Foes (?): CRSP, SNY, AGMB, BIIB, ALNY (more...)

Sep 4, 2026 05:09 AM Citi initiates Dianthus Therapeutics coverage with Buy rating
Aug 31, 2026 08:00 AM This biotech stock still Wolfe's top pick as multiple catalysts loomh
Aug 19, 2026 06:03 PM Form 4 Dianthus Therapeutics, For: Aug 19 Filed by: Read Simon
Aug 14, 2026 04:33 PM Form 4 Dianthus Therapeutics, For: Aug 13 Filed by: Veness Adam M
Aug 14, 2026 08:33 AM Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Sirenia Capital Management LP
Aug 13, 2026 04:06 PM Form SCHEDULE 13G Dianthus Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 11, 2026 05:15 PM Form 4 Dianthus Therapeutics, For: Aug 10 Filed by: McGeorge Anne
Aug 11, 2026 05:10 PM Form 4 Dianthus Therapeutics, For: Aug 10 Filed by: Read Simon
Aug 11, 2026 05:09 PM Form 4 Dianthus Therapeutics, For: Aug 07 Filed by: Veness Adam M
Aug 10, 2026 04:51 PM Form 144 Dianthus Therapeutics, Filed by: Veness Adam M
View All Articles

Entities mentioned with DNTH

View All Entities